<DOC>
	<DOCNO>NCT01657513</DOCNO>
	<brief_summary>TNF alfa blocker widely use treatment severe psoriasis . These biologics well-tolerated side effect . Unfortunately patient respond adequately treatment tnf alfa blocker . Some respond others respond initially gradually lose effect despite increase dose frequent administration . The cause treatment failure largely unknown may production tnf-alfa neutralize antibody . This demonstrated patient rheumatoid arthritis inflammatory bowel disease lose response treatment tnf-alfa blocker .</brief_summary>
	<brief_title>TNF-alfa Inhibitors Antibody Production Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Male female Age 18 Psoriasis Indication treatment tnf alfa block drug Written inform consent obtain Severe psychiatric disorder No indication treatment tnfalfa block drug Pregnancy Breastfeeding No write inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>treatment failure</keyword>
	<keyword>tnf-alfa</keyword>
</DOC>